Showing results (101-110 of 308) with videos related to

Sort By:
Pageof 31
Thrombosis and Haemostasis|July 10, 2008
Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery diseaseVictor Serebruany, Ilya Pokov, Wiktor Kuliczkowski, et al.
Cardiology|August 16, 2017
A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR StudyCai De Jin, Moo Hyun Kim, Junghee Bang, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzerAlex Malinin, Malcolm Spergling, Brent Muhlestein, et al.
Thrombosis and Haemostasis|August 12, 2008
Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stentingVictor Serebruany, Ilya Pokov, Wiktor Kuliczkowski, et al.
American Journal of Therapeutics|June 3, 2009
The antiarrhythmic properties of quifenadine, H1-histamine receptor blocker in children with premature beats: a randomized controlled pilot trialLeonid Makarov, Larisa Balykova, Olga Soldatova, et al.
International Journal of Cardiology|September 28, 2013
Cangrelor infusion is associated with an increased risk for bleeding: meta-analysis of randomized trialsVictor L Serebruany, Daniel Aradi, Moo Hyun Kim, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19Liudmila Buryachkovskaya, Nikita Lomakin, Arthur Melkumyants, et al.
Thrombosis and Haemostasis|September 5, 2021
Mild COVID-19 and Impaired Blood Cell-Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics?Arthur Melkumyants, Ludmila Buryachkovskaya, Nikita Lomakin, et al.
Ebiomedicine|June 10, 2017
CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary InterventionsJunghee Bang, Sun Young Choi, Moo Hyun Kim, et al.
International Journal of Cardiology|June 5, 2015
Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevated myocardial infarctionVictor L Serebruany, Vasily Cherepanov, Ales Tomek, et al.
Pageof 31